StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Apontis Pharma AG
XETRA:APPH.DE
Sector
Location
Market Cap
USD 106.39 M
Share Price
USD 12.77
Avg Daily Volume
816
Change (1 day)
0.71%
Change (1 year)
36.20%
Change (YTD)
22.12%
Apontis Pharma AG Accounts Payable for the year ending December 31, 2023: USD 5.62 M
Apontis Pharma AG Accounts Payable is USD 5.62 M for the year ending December 31, 2023, a -2.02% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Apontis Pharma AG Accounts Payable for the year ending December 31, 2022 was USD 5.73 M, a 67.77% change year over year.
-
Apontis Pharma AG Accounts Payable for the year ending December 31, 2021 was USD 3.42 M, a -14.16% change year over year.
-
Apontis Pharma AG Accounts Payable for the year ending December 31, 2020 was USD 3.98 M, a 13.28% change year over year.
-
Apontis Pharma AG Accounts Payable for the year ending December 31, 2019 was USD 3.51 M.
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%